Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutiform Step-down in Asthma
NCT02388373Phase 4Completed
- Sponsor
- Research in Real-Life
- Start
- Jul 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate + formoterol in asthma (3 arms), sponsored by Research in Real-Life. Primary endpoint: Asthma Control Questionnaire score at 12 weeks. Started Jul 2014; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02388373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388373.